Efficacy and safety of vonoprazan-amoxicillin dual therapy for <i>Helicobacter pylori</i> first-line treatment: a single-center, randomized, controlled trial.
Journal Information
Full Title: Therap Adv Gastroenterol
Abbreviation: Therap Adv Gastroenterol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology & Hepatology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The authors declare that there is no conflict of interest."
"Funding: The authors received no financial support for the research, authorship, and/or publication of this article."
"Registration:: This study was registered at the Chinese Clinical Trial Registry (ChiCTR2100052550) on 30 October 2021. Ethics approval and consent to participate: The research was approved by the Ethics Committee of Peking University First Hospital (Scientific Research No. 2021-374) and registered at the Chinese Clinical Trial Registry (ChiCTR2100052550) on 30 October 2021. Written informed consent was obtained from all patients."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025